Healthcare provider profile · identity verified

Eduardo Donato, MD

Internal Medicine · FLORENCE, SC · NPI 1629035878

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1068	300
Amlodipine Besylate	Amlodipine Besylate	918	251
Levothyroxine Sodium	Levothyroxine Sodium	506	127
Losartan Potassium	Losartan Potassium	503	138
Carvedilol	Carvedilol	353	108
Metformin Hcl	Metformin Hcl	345	102
Hydrochlorothiazide	Hydrochlorothiazide	307	89
Pantoprazole Sodium	Pantoprazole Sodium	276	89
Potassium Chloride	Potassium Chloride	276	97
Metoprolol Tartrate	Metoprolol Tartrate	268	75
Rosuvastatin Calcium	Rosuvastatin Calcium	260	84
Allopurinol	Allopurinol	243	69
Gabapentin	Gabapentin	237	66
Furosemide	Furosemide	213	73
Lisinopril	Lisinopril	193	48
Metoprolol Succinate	Metoprolol Succinate	192	59
Jardiance	Empagliflozin	176	38
Eliquis	Apixaban	163	35
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	160	40
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	156	41
Omeprazole	Omeprazole	151	43
Tamsulosin Hcl	Tamsulosin Hcl	150	48
Montelukast Sodium	Montelukast Sodium	148	46
Fluticasone Propionate	Fluticasone Propionate	146	65
Glimepiride	Glimepiride	146	37
Ozempic	Semaglutide	140	25
Fluoxetine Hcl	Fluoxetine Hcl	139	40
Hydralazine Hcl	Hydralazine Hcl	122	35
Pravastatin Sodium	Pravastatin Sodium	119	37
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	110	21
Simvastatin	Simvastatin	104	29
Quetiapine Fumarate	Quetiapine Fumarate	100	27
Prednisone	Prednisone	96	45
Farxiga	Dapagliflozin Propanediol	90	16
Albuterol Sulfate Hfa	Albuterol Sulfate	89	35
Donepezil Hcl	Donepezil Hcl	89	25
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	85	26
Trazodone Hcl	Trazodone Hcl	85	27
Clopidogrel	Clopidogrel Bisulfate	84	28
Escitalopram Oxalate	Escitalopram Oxalate	77	23
Famotidine	Famotidine	76	15
Azithromycin	Azithromycin	75	56
Isosorbide Mononitrate Er	Isosorbide Mononitrate	74	22
Sertraline Hcl	Sertraline Hcl	73	18
Mounjaro	Tirzepatide	71	12
Ropinirole Hcl	Ropinirole Hcl	69	25
Ezetimibe	Ezetimibe	68	22
Alendronate Sodium	Alendronate Sodium	67	17
Metformin Hcl Er	Metformin Hcl	62	18
Nifedipine Er	Nifedipine	61	17
Alprazolam	Alprazolam	60	20
Klor-Con M20	Potassium Chloride	59	24
Klor-Con M10	Potassium Chloride	58	22
Finasteride	Finasteride	56	19
Cephalexin	Cephalexin	55	44
Spironolactone	Spironolactone	54	13
Triamcinolone Acetonide	Triamcinolone Acetonide	54	23
Vitamin D2	Ergocalciferol (Vitamin D2)	53	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	52	22
Memantine Hcl	Memantine Hcl	49	11
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	48	15
Atenolol	Atenolol	46	13
Diclofenac Sodium	Diclofenac Sodium	46	17
Paroxetine Hcl	Paroxetine Hcl	45	14
Ibuprofen	Ibuprofen	43	21
Pioglitazone Hcl	Pioglitazone Hcl	40	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	40	12
Linzess	Linaclotide	38	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	38	suppressed
Trulicity	Dulaglutide	38	suppressed
Bumetanide	Bumetanide	37	suppressed
Benazepril Hcl	Benazepril Hcl	36	11
Duloxetine Hcl	Duloxetine Hcl	36	suppressed
Clonazepam	Clonazepam	35	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	17
Valsartan	Valsartan	33	suppressed
Levemir Flexpen	Insulin Detemir	32	11
Tizanidine Hcl	Tizanidine Hcl	32	suppressed
Glipizide	Glipizide	31	suppressed
Januvia	Sitagliptin Phosphate	31	suppressed
Meloxicam	Meloxicam	31	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	30	28
Xarelto	Rivaroxaban	30	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	29	suppressed
Irbesartan	Irbesartan	28	suppressed
Ranolazine Er	Ranolazine	28	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Meclizine Hcl	Meclizine Hcl	27	14
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	26	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Glipizide Er	Glipizide	25	suppressed
Ramipril	Ramipril	25	suppressed
Levetiracetam	Levetiracetam	24	suppressed
Mirtazapine	Mirtazapine	24	suppressed
Sucralfate	Sucralfate	24	suppressed
Latanoprost	Latanoprost	23	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Icosapent Ethyl	Icosapent Ethyl	22	suppressed
Synthroid	Levothyroxine Sodium	22	suppressed
Tramadol Hcl	Tramadol Hcl	22	12
Acetaminophen-Codeine	Acetaminophen With Codeine	20	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Myrbetriq	Mirabegron	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	suppressed
Sotalol	Sotalol Hcl	20	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	20	suppressed
Amiodarone Hcl	Amiodarone Hcl	19	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	19	suppressed
Novolog Flexpen	Insulin Aspart	19	suppressed
Brilinta	Ticagrelor	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Cilostazol	Cilostazol	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Bupropion Hcl	Bupropion Hcl	16	suppressed
Glyburide	Glyburide	16	suppressed
Ipratropium Bromide	Ipratropium Bromide	16	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	16	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Terazosin Hcl	Terazosin Hcl	16	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Multaq	Dronedarone Hcl	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Digoxin	Digoxin	14	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	14	suppressed
Clonidine	Clonidine	13	suppressed
Famciclovir	Famciclovir	13	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	13	suppressed
Primidone	Primidone	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	13	suppressed
Colchicine	Colchicine	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	12	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Wegovy	Semaglutide	12	suppressed
Ammonium Lactate	Ammonium Lactate	11	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Folic Acid	Folic Acid	11	suppressed
Hydroxyurea	Hydroxyurea	11	suppressed
Indapamide	Indapamide	11	suppressed
Methimazole	Methimazole	11	suppressed
Topiramate	Topiramate	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error